ANTI-ANGINAL GUIDELINES NEED NOT AGREE WITH EC DRAFT, ADVISORY COMMITTEE SAYS; RECOMMENDS WORKSHOP TO DETERMINE EARLY STAGE ISSUES IN DRUG DEVELOPMENT

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".